Form 8-K - Current report:
SEC Accession No. 0001625101-21-000004
Filing Date
2021-01-25
Accepted
2021-01-25 08:12:14
Documents
13
Period of Report
2021-01-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K plse-20210125x8k.htm   iXBRL 8-K 77017
2 EX-99.1 plse-20210125xex99_1.htm EX-99.1 19207
  Complete submission text file 0001625101-21-000004.txt   225207

Data Files

Seq Description Document Type Size
3 EX-101.SCH plse-20210125.xsd EX-101.SCH 3003
4 EX-101.LAB plse-20210125_lab.xml EX-101.LAB 15512
5 EX-101.PRE plse-20210125_pre.xml EX-101.PRE 11495
6 EXTRACTED XBRL INSTANCE DOCUMENT plse-20210125x8k_htm.xml XML 4813
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

EIN.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37744 | Film No.: 21548019
SIC: 3841 Surgical & Medical Instruments & Apparatus